Basic information Leukemia drug Chemical properties Mechanism of Action Pharmacokinetics Uses Drug Interactions Toxicology Safety Related Supplier
Dasatinib Structure


Chemical Properties

Melting point 275-286°C
Density  1.408±0.06 g/cm3(Predicted)
storage temp.  Sealed in dry,Store in freezer, under -20°C
solubility  Soluble in DMSO (up to 200 mg/ml).
pka 10.94±0.70(Predicted)
form  White powder.
color  White or off-white
Stability Stable for 1 year from date of purchase as supplied. Solutions in DMSO may be stored at -20° for up to 2 months.
CAS DataBase Reference 302962-49-8(CAS DataBase Reference)
Dasatinib is an oral potent oncogenic kinase inhibitor, which can block signal of cancer cell replication acceleration , in May 2009, the US Food and Drug Administration (FDA) formally approved the sale of dasatinib , It has been clinically used for the treatment of various chronic myeloid leukemia (CML), including treatment of chronic myeloid leukemia which is resistant or intolerant to the treating programs including imatinib mesylate., Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL) and the treatment of patients with solid tumors.

Safety Information

HS Code  29341000

Usage And Synthesis

Dasatinib Supplier

Dasatinib manufacturers